605 related articles for article (PubMed ID: 17219072)
1. Lamina propria and circulating interleukin-8 in newly and previously diagnosed pediatric inflammatory bowel disease patients.
Reddy KP; Markowitz JE; Ruchelli ED; Baldassano RN; Brown KA
Dig Dis Sci; 2007 Feb; 52(2):365-72. PubMed ID: 17219072
[TBL] [Abstract][Full Text] [Related]
2. Lamina propria and circulating interleukin-6 in newly diagnosed pediatric inflammatory bowel disease patients.
Brown KA; Back SJ; Ruchelli ED; Markowitz J; Mascarenhas M; Verma R; Piccoli DA; Baldassano RN
Am J Gastroenterol; 2002 Oct; 97(10):2603-8. PubMed ID: 12385446
[TBL] [Abstract][Full Text] [Related]
3. Expression of interleukin 1 beta and interleukin 1 beta converting enzyme by intestinal macrophages in health and inflammatory bowel disease.
McAlindon ME; Hawkey CJ; Mahida YR
Gut; 1998 Feb; 42(2):214-9. PubMed ID: 9536946
[TBL] [Abstract][Full Text] [Related]
4. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease.
Daig R; Andus T; Aschenbrenner E; Falk W; Schölmerich J; Gross V
Gut; 1996 Feb; 38(2):216-22. PubMed ID: 8801200
[TBL] [Abstract][Full Text] [Related]
5. Increased in vitro release of soluble interleukin 2 receptor by colonic lamina propria mononuclear cells in inflammatory bowel disease.
Schreiber S; Raedler A; Conn AR; Rombeau JL; MacDermott RP
Gut; 1992 Feb; 33(2):236-41. PubMed ID: 1541420
[TBL] [Abstract][Full Text] [Related]
6. Colonic mucosal interleukin 1 receptor antagonist in inflammatory bowel disease.
Nishiyama T; Mitsuyama K; Toyonaga A; Sasaki E; Tanikawa K
Digestion; 1994; 55(6):368-73. PubMed ID: 7705549
[TBL] [Abstract][Full Text] [Related]
7. Intestinal interleukin-8 concentration and gene expression in inflammatory bowel disease.
Nielsen OH; Rüdiger N; Gaustadnes M; Horn T
Scand J Gastroenterol; 1997 Oct; 32(10):1028-34. PubMed ID: 9361176
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-6 and soluble interleukin-6 receptor in the colonic mucosa of inflammatory bowel disease.
Hosokawa T; Kusugami K; Ina K; Ando T; Shinoda M; Imada A; Ohsuga M; Sakai T; Matsuura T; Ito K; Kaneshiro K
J Gastroenterol Hepatol; 1999 Oct; 14(10):987-96. PubMed ID: 10530495
[TBL] [Abstract][Full Text] [Related]
9. Mucosal cytokine production in radiation-induced proctosigmoiditis compared with inflammatory bowel disease.
Indaram AV; Visvalingam V; Locke M; Bank S
Am J Gastroenterol; 2000 May; 95(5):1221-5. PubMed ID: 10811331
[TBL] [Abstract][Full Text] [Related]
10. Increased Th17-inducing activity of CD14+ CD163 low myeloid cells in intestinal lamina propria of patients with Crohn's disease.
Ogino T; Nishimura J; Barman S; Kayama H; Uematsu S; Okuzaki D; Osawa H; Haraguchi N; Uemura M; Hata T; Takemasa I; Mizushima T; Yamamoto H; Takeda K; Doki Y; Mori M
Gastroenterology; 2013 Dec; 145(6):1380-91.e1. PubMed ID: 23993972
[TBL] [Abstract][Full Text] [Related]
11. Relationship of interleukin-1 receptor antagonist to mucosal inflammation in inflammatory bowel disease.
Hyams JS; Fitzgerald JE; Wyzga N; Muller R; Treem WR; Justinich CJ; Kreutzer DL
J Pediatr Gastroenterol Nutr; 1995 Nov; 21(4):419-25. PubMed ID: 8583293
[TBL] [Abstract][Full Text] [Related]
12. TL1A as a Potential Local Inducer of IL17A Expression in Colon Mucosa of Inflammatory Bowel Disease Patients.
Ślebioda TJ; Bojarska-Junak A; Stanisławowski M; Cyman M; Wierzbicki PM; Roliński J; Celiński K; Kmieć Z
Scand J Immunol; 2015 Oct; 82(4):352-60. PubMed ID: 26072972
[TBL] [Abstract][Full Text] [Related]
13. Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease.
Louis E; Ribbens C; Godon A; Franchimont D; De Groote D; Hardy N; Boniver J; Belaiche J; Malaise M
Clin Exp Immunol; 2000 May; 120(2):241-6. PubMed ID: 10792371
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
Griga T; May B; Pfisterer O; Müller KM; Brasch F
Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
[TBL] [Abstract][Full Text] [Related]
15. Compartmentalized expression of Th1 and Th17 cytokines in pediatric inflammatory bowel diseases.
Verdier J; Begue B; Cerf-Bensussan N; Ruemmele FM
Inflamm Bowel Dis; 2012 Jul; 18(7):1260-6. PubMed ID: 21994045
[TBL] [Abstract][Full Text] [Related]
16. A CD3-specific antibody reduces cytokine production and alters phosphoprotein profiles in intestinal tissues from patients with inflammatory bowel disease.
Vossenkämper A; Hundsrucker C; Page K; van Maurik A; Sanders TJ; Stagg AJ; Das L; MacDonald TT
Gastroenterology; 2014 Jul; 147(1):172-83. PubMed ID: 24704524
[TBL] [Abstract][Full Text] [Related]
17. Analysis of direct tissue isoelectric focused protein profiles of resected intestinal mucosa and endoscopic biopsies from patients with inflammatory bowel disease.
Szewczuk MR; Depew WT
Clin Invest Med; 1992 Feb; 15(1):49-59. PubMed ID: 1374000
[TBL] [Abstract][Full Text] [Related]
18. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease.
Banks C; Bateman A; Payne R; Johnson P; Sheron N
J Pathol; 2003 Jan; 199(1):28-35. PubMed ID: 12474223
[TBL] [Abstract][Full Text] [Related]
19. Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn's disease.
Reimund JM; Wittersheim C; Dumont S; Muller CD; Baumann R; Poindron P; Duclos B
J Clin Immunol; 1996 May; 16(3):144-50. PubMed ID: 8734357
[TBL] [Abstract][Full Text] [Related]
20. Involvement of endoplasmic reticulum stress in inflammatory bowel disease: a different implication for colonic and ileal disease?
Bogaert S; De Vos M; Olievier K; Peeters H; Elewaut D; Lambrecht B; Pouliot P; Laukens D
PLoS One; 2011; 6(10):e25589. PubMed ID: 22028783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]